Literature DB >> 20554314

Risk of malignancy in sonographically confirmed septated cystic ovarian tumors.

Brook A Saunders1, Iwona Podzielinski, Rachel A Ware, Scott Goodrich, Christopher P DeSimone, Fred R Ueland, Leigh Seamon, Jessalyn Ubellacker, Edward J Pavlik, Richard J Kryscio, John R van Nagell.   

Abstract

OBJECTIVE: To determine the risk of malignancy in septated cystic ovarian tumors. MATERIALS: 1319 (4.4%) of 29,829 women were identified by transvaginal sonography (TVS) as having a complex cystic ovarian tumor with septations without solid areas or papillary projections and were placed on long-term ultrasound surveillance for ovarian malignancy.
RESULTS: These 1319 patients had a total of 2870 septated cystic ovarian tumors. 2288 tumors (79.7%) had a septal width <2 mm and 582 (20.3%) had a septal width >or=2 mm. 2286 tumors (79.6%) were <5 cm in diameter and 584 (20.4%) were>or=5 cm in diameter. 1114 septated cystic tumors (38.8%) resolved spontaneously (mean duration to resolution-12 months) and 1756 (61.2%) tumors persisted. 128 patients underwent surgical tumor removal within 3 months of ultrasound. Most common histopathology was: serous cystadenoma (75), mucinous cystadenoma (13), and endometrioma (10). One patient had an ovarian tumor of borderline malignancy (Stage IB). There were no cases of ovarian cancer. Patients were followed from 4 to 252 months (mean-77 months). One patient developed papillary morphology in the contralateral ovary 3.2 years after detection of a septated ovarian cyst and had epithelial ovarian cancer in that ovary and in the omentum (Stage IIIC disease). The remaining patients are all free of ovarian neoplasia after a total of 7642 follow-up years.
CONCLUSIONS: Septated cystic ovarian tumors without solid areas or papillary projections have a low risk of malignancy and can be followed sonographically without surgery. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20554314     DOI: 10.1016/j.ygyno.2010.05.013

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Evaluation of whether the ultrasonographic onion skin sign is specific for the diagnosis of an appendiceal mucocele.

Authors:  Toru Kameda; Fukiko Kawai; Nobuyuki Taniguchi; Kiyoka Omoto; Yasuyuki Kobori; Kazukiyo Arakawa
Journal:  J Med Ultrason (2001)       Date:  2014-03-06       Impact factor: 1.314

2.  Management of the Adnexal Mass: Considerations for the Family Medicine Physician.

Authors:  Brian Bullock; Lisa Larkin; Lauren Turker; Kate Stampler
Journal:  Front Med (Lausanne)       Date:  2022-07-05

Review 3.  Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials.

Authors:  Eleanor L Ormsby; Edward J Pavlik; John P McGahan
Journal:  Diagnostics (Basel)       Date:  2017-04-28

4.  Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening.

Authors:  John R van Nagell; Brian T Burgess; Rachel W Miller; Lauren Baldwin; Christopher P DeSimone; Frederick R Ueland; Bin Huang; Quan Chen; Richard J Kryscio; Edward J Pavlik
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.623

Review 5.  Transvaginal ultrasonography in ovarian cancer screening: current perspectives.

Authors:  John R van Nagell; John T Hoff
Journal:  Int J Womens Health       Date:  2013-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.